Skip to content

Functional Electrical Stimulation Assisted Cycling - Therapeutic Effects on patients with subacute Hemiparesis after stroke

Functional Electrical Stimulation Assisted Cycling - Therapeutic Effects on patients with subacute Hemiparesis after stroke - RehaMove

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004330
Enrollment
40
Registered
2013-01-09
Start date
2009-03-31
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G81.0

Interventions

Group 1: Intervention group: assisted cycling with functional electrical stimulation. four weeks, three times per week, a´20 minutes. (RehaMove by Hasomed) Group 2: Controll group: assisted cycling wi

Sponsors

Schoen Klinik Bad Aibling
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ischemic or hämorrhagic Insult max. 6 months ago Motricity Index less than 14 or 14 for the M. quadriceps femoris

Exclusion criteria

Exclusion criteria: pregnancy pacemaker metal in the area of stimulation contractures or loss of Mobility in legs, that cycling is impossible Walking without help and aids

Design outcomes

Secondary

MeasureTime frame
Ashworth Scale, Motricity Index, Bioimpedance analysis, Somatosensibilität, 10-m-walking test, Barthel-Index Measurement of tone, strength, sensibility and need of care before start of therapy, after therapy and 14 days after end of therapy. Measurement of body composition before start of therapy and after end of therapy.

Primary

MeasureTime frame
Performance oriented Mobility Assessment (POMA), Functional Ambulatione Classification (FAC) Measurement of ability for walking, standing and sitting before start of therapy, after therapy and 14 days after end of therapy.

Countries

Germany

Contacts

Public ContactCarmen Krewer

Schoen Klinik Bad Aibling

ckrewer@schoen-kliniken.de+49 (0) 8061 903 1950

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026